TransformativeMed develops EHR-embedded clinical communication and collaboration solutions, centered on the CORES Value Suite, which curates and surfaces specialty-specific EHR data within clinician workflows. Its product set includes out-of-the-box clinician-designed workflows, machine-learning-powered smart messaging and texting integrated directly into workflows, and bi-directional smartphone integration. Solutions are delivered interface-free as a SaaS model to reduce IT burden and enable rapid, turnkey implementations. The company reports tens of thousands of clinicians across more than 130 hospitals and health systems use CORES, including Dignity Health, Baptist Health, and MedStar. TransformativeMed plans to use new funding to accelerate sales and marketing and pursue an aggressive nationwide expansion of the CORES Value Suite. Founded in 2011 and based in Seattle, the privately held company was co-founded by Dr. Erik Van Eaton and David Stone; Doug Cusick is CEO.

Total raised

$6M

Funding rounds

1

Latest round

Series A

Latest activity

May 2019